Brief Introduction

Beijing Balance Medical Technology Co., Ltd was founded in 2005. As a leading company with advanced technology on the research and development of animal source material medical devices, the company’s products have been widely used in heart valve replacement and repair, congenital heart disease treatment and soft tissue surgical repair. 12 products have already received CFDA class III medical device approval, during which the prosthetic tissue heart valve (both bovine pericardial valve and porcine valve), pulmonary valved conduit, annuloplasty ring, cardiothoracic surgical biopatch, neurosurgical microvascular decompression felt are the first approved domestic products in the related treatment fields, filled the vacancy of domestic medical devices. The products have been clinically used in more than 300 large hospitals in China such as Beijing Anzhen Hospital, Guangdong General Hospital. The company also has a strong product pipeline including transcatheter heart valves, ophthalmic surgical biopatch, etc., to reinforce market leader position in the related fields and ensure sustainable business growth in the future.

Company Overview

Full name Beijing Balance Medical Technology Co., Ltd.
Abbreviations Balance Medical
Code 688198
Founded July 11,2005
Listing December 9,2019
Domicile Beijing
Website http://www.bairenmedical.com
Email bairenyiliao@bairenmedical.com
STAR Theme Biomedicine
CSRCSector Manufacturing
Has weighted voting rights structure? No

Financials

Highlights

  2018 2017 2016
Earnings Per Share 0.54 - -
R&D expenditure as a % of operating revenue 11.65% 12.75% 14.57%
Operating Revenue 110,648,032.03 92,347,144.03 78,459,946.15
Net Income 33,139,784.53 41,599,207.35 31,012,035.22

Income Statement (Unit: RMB mn)

  2018 2017 2016
Operating Revenue 110.65 92.35 78.46
Operating Costs 9.91 10.05 9.35
Operating Income 41.42 47.66 35.70
Pretax Income 41.25 48.41 36.05
Income Tax 8.11 6.81 5.04
Net Income 33.14 41.60 31.01

Balance Sheet(Unit: RMB mn)

  2018 2017 2016
Assets
Current Assets-Total 151.31 83.26 54.11
Non-current Assets-Total 58.74 63.37 69.41
Total Assets 210.05 146.63 123.52
Liabilities
Current Liabilities-Total 12.03 11.32 27.44
Non-current Liabilities-Total 1.98 1.66 2.23
Total Liabilities 14.01 12.98 29.67
Stockholder's Equity
Share Capital 72.00 29.80 29.80
Retained Profits 23.04 89.10 50.60
Minority interests -0.58 -0.32 -0.12
Total Owners' Equity 196.04 133.65 93.85

Cash Flow Statement (Unit: RMB mn)

  2018 2017 2016
Net Cash Flows-Operating 53.92 46.38 45.07
Net Cash Flows-Investing -0.45 -14.62 -13.38
Net Cash Flows-Financing 12.80 - -19.62

Top 10 Shareholders

Name No. of Shares Held (mn) % of Shares Held
Jin Lei 59.92 62.42%
北京佰奥企业管理中心(有限合伙) 6.00 6.25%
北京佰奥辅仁医疗投资管理中心(有限合伙) 6.00 6.25%
国信证券-中国银行-国信证券鼎信2号科创板战略配售集合资产管理计划 2.40 2.50%
国信资本有限责任公司 1.20 1.25%
Li Feng Ling 0.08 0.08%
中国工商银行股份有限公司企业年金计划-中国建设银行股份有限公司 0.04 0.04%
中国石油天然气集团公司企业年金计划-中国工商银行股份有限公司 0.03 0.03%
中国石油化工集团公司企业年金计划-中国工商银行股份有限公司 0.03 0.03%
中国建设银行股份有限公司企业年金计划-中国工商银行股份有限公司 0.03 0.03%
04 Dec 2019

Legal Statement

All information contained herein is provided by the underlying company itself and is for informational purposes only, and nothing contained herein should be construed as investment advice, either on behalf of a particular security or an overall investment strategy. The Shanghai Stock Exchange does not guarantee its accuracy and reliability and shall under no circumstance be responsible or liable for any error or for any loss directly or indirectly arising from any inaccuracy or omission or from any decision, action or non-action based on or in reliance upon the information herein.

Users may view and download the information herein for personal and non-commercial use free of charge subject to the laws of the People's Republic of China and the Legal Statement. No part of the information herein may be copied, downloaded, stored in a retrieval system or transmitted in any form or by any means, rented, displayed, performed, reproduced, photocopied, altered, sold, broadcast, published or otherwise in whole or in part in any manner for commercial purposes, without the prior written consent of the Shanghai Stock Exchange.

Users are hereby reminded that the Legal Statement represents your legally binding agreement with the Shanghai Stock Exchange. By accessing or using this website, you are also signifying your agreement with and acceptance of all the contents in the Legal Statement. The Shanghai Stock Exchange reserves the right to amend and interpret the Legal Statement.